Please use this identifier to cite or link to this item:
Title: Upconverting nanoparticles as nanotransducers for photodynamic therapy in cancer cells
Authors: Chatterjee, D.K. 
Yong, Z. 
Keywords: HT29 cell line
Photodynamic therapy
Singlet oxygen
Upconversion wistar rats
Issue Date: Feb-2008
Citation: Chatterjee, D.K., Yong, Z. (2008-02). Upconverting nanoparticles as nanotransducers for photodynamic therapy in cancer cells. Nanomedicine 3 (1) : 73-82. ScholarBank@NUS Repository.
Abstract: Background: Photodynamic therapy (PDT) involves killing of diseased cells by excitation of photosensitizer chemicals with high-energy light to produce cytotoxic oxygen species from surrounding dissolved oxygen. However, poor tissue penetration of high-energy light and hydrophobic photosensitizers limits the effectiveness to superficial pathologies. Upconversion phosphor nanoparticles convert low-energy radiation to higher-energy emissions. Aim: To create upconverting 'nanotransducers' to enable PDT in deep tissues. Results: Monodisperse, 50 nm PEI/NaYP4:Yb3+,Er3+ nanoparticles producing green/red emission on near-infrared (NIR) excitation were targeted to folate receptors on human colon cancer cells and imaged with high signal-to-background ratio. It was demonstrated that these particles could be excited after deep intramuscular injection in rats. On NIR excitation, the particles, modified with zinc phthalocyanin photosensitizer, released singlet oxygen and, after targeted binding to cancer cells, resulted in significant cell destruction. Conclusion: Potential clinical use of these nanoparticles includes imaging and PDT of cancer in deep tissues. © 2008 Future Medicine Ltd.
Source Title: Nanomedicine
ISSN: 17435889
DOI: 10.2217/17435889.3.1.73
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.


checked on Jan 14, 2019


checked on Jan 7, 2019

Page view(s)

checked on Nov 23, 2018

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.